SEC Filing Details

Detailed Financial Reporting & Filings

Access Aprea Therapeutics’ quarterly and annual reports, earnings disclosures, and SEC filings. These financial documents reflect our commitment to transparency, regulatory compliance, and delivering clear insight into our operational and fiscal performance.

Document Details

Form
Filing Date
Aug 12, 2026
Document Date
Jun 30, 2026
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.